Physician profile
Selvakumar Kunchithapatham
NPI 1871514810
$4,151.96
in general payments reported to CMS, 2019-2025
20 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2021: $371 · 2022: $472 · 2023: $591 · 2024: $882 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,920.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,553.85 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $580.18 | 2022-2025 | Symplicity G3, Hawkone |
| Amgen INC. | $348.67 | 2019-2025 | Repatha, Repatha |
| Abiomed | $307.01 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $304.28 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $275.96 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $144.08 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $110.03 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $90.09 | 2019-2025 | Eluvia, Rotapro |
| Philips North America LLC | $87.10 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.41 | 2022-2023 | Jardiance |
| Abbott Laboratories | $51.81 | 2022-2024 | Aveir |
| Astrazeneca Pharmaceuticals Lp | $46.50 | 2019-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $44.57 | 2023-2025 | |
| Cardiva Medical, INC. | $33.08 | 2021-2024 | Savvywire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $30.43 | 2019-2025 | Guideliner |
| Terumo Medical Corporation | $30.22 | 2022 | |
| Pfizer INC. | $24.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.87 | 2019 | |
| Amarin Pharma, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selvakumar Kunchithapatham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.